Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.

Modern Synthesis’s fibers can be manipulated in ways that simple plant fibers cannot. They can be spread into a thin, ...